U.S. Office REITs Stock News

NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

ATI Stock And Two Aerospace And Defense Quiet Margin Stories

Global inflation questions, shifting central bank policies and energy price swings have put resilience and reliability at the top of many investors’ wish lists. Aerospace and defense companies sit at the crossroads of government spending, long-term contracts and critical infrastructure, which can offer a different risk and return profile compared with more cyclical areas of the market. This Aerospace And Defense screener filters for companies that manufacture or provide services to these...
NYSE:EQT
NYSE:EQTOil and Gas

EQT (EQT) Stock Could Be 27% Undervalued After Strong Gas Led Earnings

EQT (EQT) stock is drawing attention after the company reported fourth quarter results that exceeded Wall Street profit estimates, supported by higher natural gas demand from data centers and liquefied natural gas exports. See our latest analysis for EQT. Despite the upbeat quarter, EQT's recent share price return shows pressure, with the stock down 11% over the past month and 20.95% over the last 90 days, while the 5 year total shareholder return of 164.80% still reflects strong longer term...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian (RIVN) Stock Could Be 10.4% Undervalued After R2 Deliveries Begin

Rivian Automotive (RIVN) is back in focus after beginning deliveries of its R2 SUV while aligning with partners like AT&T and ChargeScape, moves that collectively broaden its reach and technology footprint. See our latest analysis for Rivian Automotive. Rivian Automotive’s recent news around R2 deliveries, ChargeScape participation, workforce reductions and an autonomy roadmap has come alongside a 1‑month share price return of 21.8%, while the year to date share price return has fallen 16.2%...
NYSE:WAB
NYSE:WABMachinery

Westinghouse Air Brake Technologies (WAB) Stock Could Be 9.4% Undervalued After Battery Rail Deal

Westinghouse Air Brake Technologies (WAB) is back in focus after Forsee Power announced a Memorandum of Understanding to integrate its PULSE PLUS RAIL battery systems into Wabtec’s battery electric locomotive platforms. See our latest analysis for Westinghouse Air Brake Technologies. The Forsee Power agreement comes as Westinghouse Air Brake Technologies trades at $271.86, with a 7 day share price return of 5.98% and a 90 day share price return of 14.64%. The 1 year total shareholder return...
NYSE:WCN
NYSE:WCNCommercial Services

How Investors Are Reacting To Waste Connections (WCN) Dividend Hike Amid Slowing Demand Concerns

Earlier in June 2026, Waste Connections announced an 11.1% increase in its dividend, highlighting management’s emphasis on returning more cash to shareholders while running a large North American waste management network. The dividend hike comes even as the company faces signs of slowing demand and pressure on profitability, underscoring a tension between income-focused capital returns and operational headwinds. We’ll now examine how this sizable dividend increase, set against concerns about...
NasdaqCM:TOYO
NasdaqCM:TOYOSemiconductor

TOYO (TOYO) Stock Could Be 30.6% Undervalued After US Solar Deals And Texas Expansion

TOYO (NasdaqCM:TOYO) is drawing attention after signing two master supply agreements with major U.S. solar developers worth about US$185.6 million, alongside plans for a new 1.5 GW HJT cell facility in Texas. See our latest analysis for TOYO. Those supply deals and the planned Texas HJT facility come after a sharp run in TOYO’s share price, with a 90 day share price return of 40.49% and a year to date share price return of 109.56%. The 1 year total shareholder return of 237.58% points to...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders

Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress. An additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Futu Holdings (FUTU) Stock Could Be 58.2% Undervalued After Regulatory Investigation

Pomerantz LLP is investigating Futu Holdings (NasdaqGM:FUTU) after a Reuters report that Chinese regulators may penalize the broker for soliciting clients without an onshore license, bringing regulatory risk into focus. See our latest analysis for Futu Holdings. The investigation comes after a difficult period for Futu Holdings, with the share price down 46.2% year to date and 33.6% over 90 days. However, the three year total shareholder return is 152.7%, suggesting long term holders have...
NYSE:WLY
NYSE:WLYMedia

Wiley (WLY) Stock Faces 163% Earnings Rebound That Challenges Long‑Term Bearish Narratives

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...
NYSE:CRL
NYSE:CRLLife Sciences

What Charles River Laboratories (CRL)'s Morgan Stanley Upgrade Means For Shareholders

In recent days, Morgan Stanley upgraded Charles River Laboratories International to Overweight from Equal Weight, signaling a shift in its analyst assessment of the company’s outlook. This change in stance adds a contrasting voice to views that currently see better value in a peer like Labcorp, sharpening the debate around Charles River’s positioning in medical services. With Morgan Stanley’s upgraded view now in play, we’ll examine how this change in analyst sentiment might influence...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Applied Optoelectronics (AAOI) Stock Could Be 119% Overvalued After AI Optics Rally

Applied Optoelectronics (AAOI) stock is back in focus after a series of AI related catalysts, including a Texas manufacturing expansion, stronger QuantumLink software ties with Spectrum, and public support for optics from Nvidia’s CEO. See our latest analysis for Applied Optoelectronics. After surging on AI infrastructure enthusiasm and the expanded QuantumLink deal with Spectrum, Applied Optoelectronics’ share price has recently pulled back, with a 1-day share price return of 10.83% down and...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA (MARA) Is Up 10.3% After Pivoting Bitcoin Into AI Infrastructure Investment - Has The Bull Case Changed?

In recent sessions, Marathon Digital Holdings, Inc. (MARA) reported an expected quarterly EPS of US$0.44 loss, while moving further into artificial intelligence by deploying AI inference racks and investing in a high-performance computing data center business. The company also sold 15,133 Bitcoin to reinforce its balance sheet amid industry-wide pressure on mining profitability, underscoring a meaningful shift in how it balances digital assets against new infrastructure growth. Next, we’ll...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

Do Upgraded Estimates And Momentum at TriMas (TRS) Reveal a Deeper Shift in Its Narrative?

In recent days, analysts highlighted that TriMas holds a Zacks Rank #2 (Buy) and a Momentum Style Score of B, supported by upward earnings estimate revisions and recent outperformance versus its industry and the broader market. This renewed analyst attention underscores how improving earnings expectations and momentum indicators can materially influence how investors assess TriMas' near-term prospects. We’ll now examine how the upgraded earnings estimates and momentum profile may influence...
NYSE:TR
NYSE:TRFood

Tootsie Roll Industries (TR) Stock Could Be 21% Undervalued After Mr. Owl Campaign Launch

Marketing refresh puts Mr. Owl and flavor variety in focus Tootsie Roll Industries (TR) has launched a new Mr. Owl TV and digital campaign featuring a color changing chameleon. The campaign spotlights the broader range of Tootsie Roll flavors and extends the character’s role across social platforms. See our latest analysis for Tootsie Roll Industries. The new Mr. Owl campaign arrives after a softer patch for the Tootsie Roll Industries share price, which is down 10.65% over the past 30 days...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Why Celldex Therapeutics (CLDX) Is Up 12.2% After CSU Drug Data Suggest Disease Modification Potential

In June 2026, Celldex Therapeutics reported long-term Phase 2 results for barzolvolimab in chronic spontaneous urticaria and Phase 1 data for CDX-622, showing rapid, durable angioedema improvement and mast cell depletion, respectively, presented at the European Academy of Allergy and Clinical Immunology meeting in Istanbul. The finding that up to 64% of barzolvolimab-treated patients with baseline angioedema remained angioedema-free seven months after dosing raises the prospect of shifting...
NYSE:TX
NYSE:TXMetals and Mining

Should Upgraded Analyst Momentum and Valuation Views Require Action From Ternium (TX) Investors?

Recent research updates highlighted that Ternium S.A. received a favorable Zacks Rank #2 (Buy) and a Momentum Score of B, supported by upward earnings estimate revisions and stronger momentum signals relative to other steel producers. Analysts also pointed out that Ternium’s improving earnings outlook and valuation metrics have made it stand out versus peers like Commercial Metals, reinforcing its position as a preferred steel producer in current coverage. We’ll now examine how these upward...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis (ENOV) Stock Could Be 49.8% Undervalued After Spinamic Brace Launch

Enovis stock reaction to the new Spinamic scoliosis brace launch Enovis (ENOV) has drawn fresh investor attention after launching the DonJoy Spinamic Hybrid Scoliosis Brace, a hybrid rigid and soft brace for adolescent idiopathic scoliosis that is now available in the United States. See our latest analysis for Enovis. For context, Enovis shares have pulled back over the year, with the year to date share price return down 18.6% and the 1 year total shareholder return down 30.1%, so the recent...
NYSE:DOW
NYSE:DOWChemicals

Dow (DOW) Stock Could Be 22.7% Undervalued After Xylem Water Reuse Deal

Dow stock reacts to new water sustainability agreement Dow (DOW) is in focus after Xylem Inc. agreed to design, build and operate advanced water treatment and reuse systems at Dow’s Fort Saskatchewan industrial complex in Alberta, Canada. See our latest analysis for Dow. Despite the sustainability focus of the new Xylem agreement and recent conference appearances, Dow’s share price has eased in the short term, with a 30-day share price return down 14.9%, while the 1-year total shareholder...
NYSE:BBY
NYSE:BBYSpecialty Retail

Is Best Buy’s (BBY) AI Hardware Push Quietly Rewriting Its In-Store Experience Strategy?

Earlier this month, GEEKOM announced that its Mini PCs are now available through Best Buy’s online marketplace and select U.S. stores, while Meta Platforms expanded its Meta Lab experiential spaces for AI glasses and VR headsets to more than 50 Best Buy locations. Together, these partnerships highlight Best Buy’s push to deepen its role as a hands-on destination for emerging AI-enabled hardware and compact computing solutions. Next, we’ll explore how Best Buy’s expanded AI wearables...
NYSE:RS
NYSE:RSMetals and Mining

Did Reliance’s (RS) Q1 Beat and New Contracts Just Redefine Its Demand Outlook?

In early June 2026, Reliance, Inc. reported first-quarter adjusted earnings and sales that surpassed analyst estimates and presented at the 16th Annual Wells Fargo Industrials & Materials Conference in Chicago, featuring President and CEO Karla R. Lewis and Executive VP and COO Stephen P. Koch. The company is expected to benefit from stronger demand in non-residential construction, public infrastructure and manufacturing, supported by new multiyear contracts that may reinforce its...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

How GuruFocus Overvaluation Alert and Insider Quiet May Shape Himax Technologies (HIMX) Investors’ View

Recently, Himax Technologies drew attention when GuruFocus assessed the stock as significantly overvalued relative to its GF Value™-based intrinsic estimate, flagging elevated risk for investors. An absence of insider share transactions over the past three months adds an extra dimension to the market’s response to these overvaluation concerns. Next, we’ll examine how GuruFocus’s overvaluation warning may influence Himax Technologies’ existing investment narrative around growth, margins, and...
NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Stock Could Be 35% Undervalued If This Housing Narrative Holds

PulteGroup (PHM) has drawn investor attention after recent share price moves, with the stock up 13.3% over the past month and 6.6% in the past 3 months, outpacing its shorter term returns. See our latest analysis for PulteGroup. Looking beyond the recent move, PulteGroup’s 1-year total shareholder return of 27.38% and 3-year total shareholder return of 70.49% indicate that the latest share price strength around $124.76 continues a broader period of positive momentum. If you want to see what...
NYSE:BKD
NYSE:BKDHealthcare

Does Brookdale Senior Living’s (BKD) Broad-Based Occupancy Gain Hint at Emerging Operational Resilience?

Brookdale Senior Living Inc. recently reported its May 2026 operating results, highlighting a year-over-year increase of 250 basis points in weighted average occupancy to 82.5% and sequential growth consistent with seasonal patterns. The company also disclosed that same community weighted average occupancy reached 82.9%, suggesting broad-based improvement across its existing senior living portfolio rather than gains driven solely by newer communities. Next, we’ll consider how this...
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

How Positive CIRRUS-HCM Phase 2 Data and Preserved Systolic Function Will Impact Edgewise Therapeutics (EWTX) Investors

Edgewise Therapeutics recently reported positive top-line results from the 12-week Phase 2 Part D CIRRUS-HCM trial of its oral cardiac sarcomere modulator EDG-7500 in patients with obstructive and nonobstructive hypertrophic cardiomyopathy, showing improvements in heart function measures, symptoms, and heart failure biomarkers without new safety concerns. A distinctive aspect of the data is that EDG-7500 improved diastolic function and clinical status across both patient groups while...